Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / EYEN - Eyenovia rises on positive data from Optejet delivery technology trial


EYEN - Eyenovia rises on positive data from Optejet delivery technology trial

  • Eyenovia ( NASDAQ: EYEN ) is trading ~5% higher premarket after it announced positive results from a research study that showed Optejet delivery technology decreased inflammation from preserved glaucoma solutions sompared to drops.
  • The study evaluated the gene and protein expression of cytokines and chemokines after latanoprost+benzalkonium chloride ( BAK ) treatment was administered via Optejet versus latanoprost+BAK administered via standard eye drops.

For further details see:

Eyenovia rises on positive data from Optejet delivery technology trial
Stock Information

Company Name: Eyenovia Inc.
Stock Symbol: EYEN
Market: NASDAQ
Website: eyenovia.com

Menu

EYEN EYEN Quote EYEN Short EYEN News EYEN Articles EYEN Message Board
Get EYEN Alerts

News, Short Squeeze, Breakout and More Instantly...